276 related articles for article (PubMed ID: 24732467)
1. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.
Mellott TJ; Pender SM; Burke RM; Langley EA; Blusztajn JK
PLoS One; 2014; 9(4):e94287. PubMed ID: 24732467
[TBL] [Abstract][Full Text] [Related]
2. BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.
Burke RM; Norman TA; Haydar TF; Slack BE; Leeman SE; Blusztajn JK; Mellott TJ
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19567-72. PubMed ID: 24218590
[TBL] [Abstract][Full Text] [Related]
3. Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
Mellott TJ; Huleatt OM; Shade BN; Pender SM; Liu YB; Slack BE; Blusztajn JK
PLoS One; 2017; 12(1):e0170450. PubMed ID: 28103298
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
5. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
6. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.
Liu W; Li J; Yang M; Ke X; Dai Y; Lin H; Wang S; Chen L; Tao J
Alzheimers Res Ther; 2022 Apr; 14(1):53. PubMed ID: 35418161
[TBL] [Abstract][Full Text] [Related]
7. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
[TBL] [Abstract][Full Text] [Related]
8. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
[TBL] [Abstract][Full Text] [Related]
10. Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer's Disease.
Unger MS; Marschallinger J; Kaindl J; Höfling C; Rossner S; Heneka MT; Van der Linden A; Aigner L
Mol Neurobiol; 2016 Oct; 53(8):5796-806. PubMed ID: 27544234
[TBL] [Abstract][Full Text] [Related]
11. PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation.
Roltsch E; Holcomb L; Young KA; Marks A; Zimmer DB
J Neuroinflammation; 2010 Nov; 7():78. PubMed ID: 21080947
[TBL] [Abstract][Full Text] [Related]
12. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of NSC-derived cholinergic neuron-like cells improves cognitive function in APP/PS1 transgenic mice.
Gu G; Zhang W; Li M; Ni J; Wang P
Neuroscience; 2015 Apr; 291():81-92. PubMed ID: 25681520
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
Zhang C; McNeil E; Dressler L; Siman R
Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
[TBL] [Abstract][Full Text] [Related]
15. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
[TBL] [Abstract][Full Text] [Related]
16. Loss of Cholinergic and Monoaminergic Afferents in
Lee MK; Chen G
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732223
[TBL] [Abstract][Full Text] [Related]
17. Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APP
Olesen LØ; Sivasaravanaparan M; Severino M; Babcock AA; Bouzinova EV; West MJ; Wiborg O; Finsen B
Neurobiol Dis; 2017 Aug; 104():50-60. PubMed ID: 28461249
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
Zeng Q; Zheng M; Zhang T; He G
Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice.
Pascual-Lucas M; Viana da Silva S; Di Scala M; Garcia-Barroso C; González-Aseguinolaza G; Mulle C; Alberini CM; Cuadrado-Tejedor M; Garcia-Osta A
EMBO Mol Med; 2014 Oct; 6(10):1246-62. PubMed ID: 25100745
[TBL] [Abstract][Full Text] [Related]
20. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
Moon M; Cha MY; Mook-Jung I
J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
